Relationship between the severity of enthesitis and clinical and laboratory parameters in patients with ankylosing spondylitis

Rheumatology International

Volumn 27, Issue 4, 2007, Pages 323-327

  Kaya, Taciser ^a,c   Bal, Serpil ^b   Gunaydin, Rezzan ^a  

^a Klinik FTR   (Turkey)

^b ATATURK TRAINING AND RESEARCH HOSPITAL   (Turkey)

^c NONE   (Turkey)

Author keywords

Ankylosing spondylitis; Enthesitis

Indexed keywords

ADULT; ANKYLOSING SPONDYLITIS; ARTICLE; CALCULATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DATA ANALYSIS; DISEASE ACTIVITY; DISEASE SEVERITY; ENTHESITIS; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORNING STIFFNESS; OUTCOME ASSESSMENT; PAIN; PRIORITY JOURNAL; VISUAL ANALOG SCALE;

ADULT; BIOLOGICAL MARKERS; BLOOD SEDIMENTATION; C-REACTIVE PROTEIN; FEMALE; HUMANS; INFLAMMATION; JOINT CAPSULE; MALE; MIDDLE AGED; PROGNOSIS; SEVERITY OF ILLNESS INDEX; SPONDYLITIS, ANKYLOSING;

EID: 33846315491     PISSN: 01728172     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00296-006-0218-0     Document Type: Article

References (25)

1. Calin A (1989) Ankylosing spondylitis. In: Kelley WN, Haris ED (eds) Textbook of rheumatology, 3rd edn. W. B. Saunders, Philadelphia, pp 1021-1037
2. Heuft-Dorenbosch L, Spoorenberg A, van Tubergen A, Landewe R et al (2003) Assessment of enthesitis in ankylosing spondylitis. Ann Rheum Dis 62(2):127-132
3. Benjamin M, McGonagle D (2001) The anatomical basis for disease localisation in seronegative spondylarthropathy at entheses and related sites. J Anat 199:503-526
4. Drouart M, Saas P, Billot M et al (2003) High serum vascular endothelial growth factor correlates with disease activity of spondylarthropathies. Clin Exp Immunol 132(1):158-162
5. D'Agostino MA, Said-Nahal R, Hacquard-Bouder C et al (2003) Assessment of peripheral enthesitis in the spondylarthropathies by ultrasonography combined with power Doppler: a cross-sectional study. Arthritis Rheum 48(2):523-533
6. McGonagle D, Marzo-Ortega H, O'Connor P et al (2002) The role of biomechanical factors and HLA-B27 in magnetic resonance imaging-determined bone changes in plantar fascia enthesopathy. Arthritis Rheum 46(2):489-493
7. Mander M, Simpson JM, McLellan A et al (1987) Studies with an enthesitis index as a method of clinical assessment in ankylosing spondylitis. Ann Rheum Dis 46:197-202
8. Davis JC Jr (2005) Ankylosing spondylitis. In: Koopman WJ, Moreland LW (eds) Arthritis and allied conditions. A textbook of rheumatology. Lippincott Williams and Wilkins, Philadelphia, pp 1319-1334
9. Garret S, Jenkinson T, Kennedy L et al (1994) A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 21:2286-2291
10. Calin A, Garret S, Whitelock H, Kennedy LG et al (1994) A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol 21(12):2281-2285
11. Jenkinson TR, Mallorie PA, Whitelock HC et al (1994) Defining spinal mobility in ankylosing spondylitis (AS). The bath AS metrology index. J Rheumatol 21(9):1694-1698
12. Karatepe AG, Akkoc Y, Akar S, Kirazli Y, Akkoc N (2005) The Turkish versions of the bath ankylosing spondylitis and Dougados functional indices: reliability and validity. Rheumatol Int 25(8):612-618. Epub 2004 Jul 10
13. Akkoc Y, Karatepe AG, Akar S, Kirazli Y, Akkoc N (2005) A Turkish version of the Bath Ankylosing Spondylitis Disease Activity Index: reliability and validity. Rheumatol Int 25(4):280-284. Epub 2004 Jan 17
14. Averns HL, Oxtoby J, Taylor HG, Jones PW et al (1996) Radiological outcome in ankylosing spondylitis: use of the stoke ankylosing spondylitis spine score(SASSS). Br J Rheumatol 35:373-376
15. Dawes PT, Sheeran TP, Beswick EJ, Hothersall TE (1987) Enthesopathy index in ankylosing spondylitis. Ann Rheum Dis 46:717
16. Balint PV, Kane D, Wilson H et al (2002) Ultrasonography of enthesal insertions in the lower limb in spondylarthropathy. Ann Rheum Dis 61(10):905-910
17. Yildirim K, Erdal A, Karatay S et al (2004) Relationship between some acute phase reactants and the Bath Ankylosing Spondylitis Disease Activity Index in patients with Ankylosing Spondylitis. South Med J 97(4):350-353
18. Taylor HG, Wardle T, Beswick EJ et al (1991) The relationship of clinical and laboratory measurements to radiological change in ankylosing spondylitis. Br J Rheumatol 30(5):330-335
19. Spoorenberg A, van der Heijde D, de Klerk E, Dougados M et al (1999) Relative value of erythrocyte sedimentation rate and C-reactive protein in assessment of disease activity in ankylosing spondylitis. J Rheumatol 26(4):980-984
20. Laurent MR, Panayi GS (1983) Acute-phase proteins and serum immunoglobulins in ankylosing spondylitis. Ann Rheum Dis 42:524-528
21. Sheenan NJ, Slavin BM, Donovan MP, Mount JN, Mathews JA (1986) Lack of correlation between clinical disease activity and erythrocyte sedimentation rate, acute phase protein or protease inhibitors in ankylosing spondylitis. Br J Rheumatol 25:171-174
22. van Tubergen A, van der Heijde D, Anderson J et al (2003) Comparison of statistically derived ASAS improvement criteria for ankylosing spondylitis with clinically relevant improvement according to an expert panel. Ann Rheum Dis 62(3):215-221
23. Garrett S, Jenkinson T, Kennedy LG, Whitelock H et al (1994) A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spodylitis Disease Activity Index. J Rheumatol 21(12):2286-2291
24. Spoorenber A, van Tubergen A, Landewe R, Dougados M, van der Linden S, Mielants H, van de Tempel H, van der Heijde D (2005) Measuring disease activity in ankylosing spondylitis: patient and physician have different perspectives. Rheumatology (Oxford) 44:789-95
25. Heuft-Dorenbosch L, van Tubergen A, Spoorenberg A, Landewe R, Dougados M, Mielants H, van der Tempel H, van der Heijde D (2004) The influence of peripheral arthritis on disease activity in ankylosing spondylitis patients as measured with the Bath Ankylosing Spondylitis Disease Activity Index. Arthritis Rheum 51(2):154-159